Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV.

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Maëliss CalonLucette A Cysique

Abstract

It is unclear whether intermediate to high cardiovascular disease (CVD) risk and HIV disease status may have additive (ie, independent statistical effects concomitantly tested) or synergistic effects on white matter microstructure and cognition in virally suppressed HIV-infected (HIV+) men relative to sex and age-matched controls. Tertiary health care observational cohort. Eighty-two HIV+ men (mean age 55 ± 6 years, 10%-30% on various CVD drugs; 20% with previous CVD) and 40 HIV-uninfected (HIV-) men (none with previous CVD; 10%-20% on various CVD drugs) underwent diffusion tensor imaging and neuropsychological testing. A standard classification of intermediate to high CVD risk (CVD+ group) was based on the Framingham score ≥15% cutoff and/or a history of CVD. Fractional anisotropy (FA) and mean diffusivity (MD) were quantified in 11 white matter tracts. Within the HIV- group, the CVD+ group had lower FA (P = 0.03) and higher MD (P = 0.003) in the corona radiata and higher MD in the corpus callosum (P = 0.02) and superior fasciculi (P = 0.03) than the CVD- group. Within the HIV+ group, the CVD+ group had lower FA in the superior fasciculi (P = 0.04) and higher MD in the uncinate fasciculus (P = 0.04), and lower FA (P = 0.01) an...Continue Reading

References

Oct 27, 2004·NeuroImage·Stephen M SmithPaul M Matthews
Nov 14, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Victor G ValcourCecilia M Shikuma
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Mar 15, 2008·AJNR. American Journal of Neuroradiology·P MukherjeeR G Henry
Mar 15, 2008·AJNR. American Journal of Neuroradiology·P MukherjeeR G Henry
Oct 21, 2009·Neurology·J T BeckerUNKNOWN Multicenter AIDS Cohort Study
Jun 15, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Nina Friis-MøllerUNKNOWN DAD study group
Sep 1, 2011·AIDS Research and Human Retroviruses·Victor ValcourPhyllis C Tien
Jul 23, 2013·Lancet Neurology·Joanna M WardlawUNKNOWN STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1)
Apr 10, 2014·Seminars in Neurology·Mary C Masters, Beau M Ances
Jul 1, 2014·TheScientificWorldJournal·Hediye Pınar GunbeyHalil Arslan
Aug 15, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Robert C KalayjianMarlene Smryzynski
Nov 12, 2014·Journal of Clinical Research in HIV AIDS and Prevention·Pariya L FazeliDavid E Vance
Mar 21, 2015·Lancet Neurology·Michael T HenekaMarkus P Kummer
May 27, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Meredith GreeneSteven G Deeks
Dec 14, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Olivia A SkrobotPatrick G Kehoe
Jan 20, 2017·Journal of Neurovirology·Christa WatsonVictor G Valcour
Mar 21, 2017·Current Atherosclerosis Reports·Revery P BarnesHossein Bahrami
May 5, 2017·AIDS·Franck Boccara
Jul 19, 2017·The Lancet. HIV·Karl GoodkinUNKNOWN Multicenter AIDS Cohort Study
Oct 23, 2017·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Olivia A SkrobotPatrick G Kehoe
Dec 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antoine MoulignierUNKNOWN Microvascular Brain Retina and Kidney (MicroBREAK) Study Group
Feb 16, 2018·Nature Reviews. Disease Primers·Wiesje M van der FlierPhilip Scheltens
Mar 27, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel M HuckJorge R Kizer
Jun 11, 2018·International Journal of Cardiology·Ozan M DemirLorenzo Azzalini
Aug 15, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jose GutierrezSusan Morgello
Dec 12, 2018·Neuroscience Letters·Rajikha RajaArvind Caprihan

❮ Previous
Next ❯

Citations

Feb 26, 2021·Current HIV/AIDS Reports·Anna H BoerwinkleBeau M Ances

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.